Bonnie L. Bassler - Feb 26, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Bonnie L. Bassler
Stock symbol
REGN
Transactions as of
Feb 26, 2024
Transactions value $
-$501,580
Form type
4
Date filed
2/26/2024, 04:07 PM
Previous filing
Jan 31, 2024
Next filing
Apr 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $335K +854 +61.79% $391.92 2.24K Feb 26, 2024 Direct
transaction REGN Common Stock Sale -$836K -854 -38.19% $979.25 1.38K Feb 26, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -854 -100% $0.00* 0 Feb 26, 2024 Common Stock 854 $391.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.